Selinexor for multiple myeloma receives accelerated FDA approval

The US Food and Drug Administration (FDA) has granted accelerated approval to a new cancer drug called selinexor. This pill, which also goes by the market name Xpovio, has been found to be successful in treating multiple myeloma in patients that hadn't had success with other treatments. But at this very early stage the drug comes with some major caveats... Continue Reading FDA approves risky new type of cancer drug – with caveats Category: Medical Tags: Blood Cancer Cells Drug Drugs FDA Tumor University of Pennsylvania

Selinexor for multiple myeloma receives accelerated FDA approval

A first-in-class drug recently granted accelerated approval by the U.S. Food and Drug Administration (FDA) for adult patients with heavily pretreated multiple myeloma has been the subject of ...

Wed 24 Jul 19 from Medical Xpress

FDA approves risky new type of cancer drug – with caveats

The US Food and Drug Administration (FDA) has granted accelerated approval to a new cancer drug called selinexor. This pill, which also goes by the market name Xpovio, has been found ...

Thu 18 Jul 19 from Gizmag

Promising system delivers chemo drug straight into tumors with fewer side effects

A stealthy new drug-delivery system disguises chemotherapeutics as fat in order to outsmart, penetrate and destroy tumors.

Wed 17 Jul 19 from Medical Xpress

‘Trojan horse’ anticancer drug disguises itself as fat, Fri 19 Jul 19 from Science Blog

'Trojan horse' anticancer drug disguises itself as fat, Thu 18 Jul 19 from ScienceDaily

'Trojan horse' anticancer drug disguises itself as fat, Wed 17 Jul 19 from Eurekalert

“Trojan horse” anticancer system hides tumor-killing drug in fat cells

A new drug delivery system has been developed that hides chemotherapy molecules inside fat cells that are quickly eaten up by hungry tumors. The method has been shown to be effective ...

Wed 17 Jul 19 from Gizmag

Moffitt research of Selinexor for multiple myeloma facilitates FDA approval

(H. Lee Moffitt Cancer Center & Research Institute) A first-in-class drug recently granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with heavily pretreated ...

Wed 24 Jul 19 from Eurekalert

  • Pages: 1

Total number of sources: 8

Bookmark

Bookmark and Share